ALKOHOLBEHANDLING - Statens Institut for Folkesundhed

210
Kiefer F, Wiedemann K. Combined therapy: what does acamprosate and naltrexone combination tell us? Alcohol Alcohol
2004; 39(6):542-547.
211
Johnson BA. Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment. CNS Drugs
2004; 18(15):1105-1118.
212
Kessler RC, Stein MB, Berglund P. Social phobia subtypes in the National Comorbidity Survey. Am J Psychiatry 1998;
155(5):613-619.
213
Pettinati HM. Antidepressant treatment of co-occurring depression and alcohol dependence. Biol Psychiatry 2004;
56(10):785-792.
214
Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV
disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62(6):617-627.
215
Gilles DM, Turk CL, Fresco DM. Social anxiety, alcohol expectancies, and self-efficacy as predictors of heavy drinking in
college students. Addict Behav 2005.
216
Zimmermann P, Wittchen HU, Hofler M, Pfister H, Kessler RC, Lieb R. Primary anxiety disorders and the development of
subsequent alcohol use disorders: a 4-year community study of adolescents and young adults. Psychol Med 2003;
33(7):1211-1222.
217
Willinger U, Lenzinger E, Hornik K, Fischer G, Schönbeck G, Aschauer HN et al. Anxiety as a predictor of relapse in
detoxified alcohol-dependent patients. Alcohol and alcoholism (Oxford, Oxfordshire) 2002; 37(6):609-612.
218
Schade A, Marquenie LA, Van Balkom AJ, De Beurs E, Van Dyck R, Van den BW. Do comorbid anxiety disorders in alcoholdependent
patients need specific treatment to prevent relapse? Alcohol Alcohol 2003; 38(3):255-262.
219
Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA
2004; 291(15):1887-1896.
220
Pettinati HM, Volpicelli JR, Luck G, Kranzler HR, Rukstalis MR, Cnaan A. Double-blind clinical trial of sertraline treatment
for alcohol dependence. J Clin Psychopharmacol 2001; 21(2):143-153.
221
Gual A, Balcells M, Torres M, Madrigal M, Diez T, Serrano L. Sertraline for the prevention of relapse in detoxicated alcohol
dependent patients with a comorbid depressive disorder: a randomized controlled trial. Alcohol Alcohol 2003; 38(6):619-
625.
222
Moak DH, Anton RF, Latham PK, Voronin KE, Waid RL, Durazo-Arvizu R. Sertraline and cognitive behavioral therapy for
depressed alcoholics: results of a placebo-controlled trial. J Clin Psychopharmacol 2003; 23(6):553-562.
223
Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J et al. Placebo-controlled trial of fluoxetine as an
adjunct to relapse prevention in alcoholics. Am J Psychiatry 1995; 152(3):391-397.
224
Randall CL, Johnson MR, Thevos AK, Sonne SC, Thomas SE, Willard SL et al. Paroxetine for social anxiety and alcohol use
in dual-diagnosed patients. Depress Anxiety 2001; 14(4):255-262.
225
Chick J, Aschauer H, Hornik K, Investigators’ Group. Efficacy of fluvoxamine in preventing relapse in alcohol dependence:
a one-year, double-blind, placebo-controlled multicentre study with analysis by typology. Drug and alcohol dependence
2004; 74(1):61-70.
226
Mason BJ, Kocsis JH, Ritvo EC, Cutler RB. A double-blind, placebo-controlled trial of desipramine for primary alcohol
dependence stratified on the presence or absence of major depression. JAMA 1996; 275(10):761-767.
Alkoholbehandling – en medicinsk teknologivurdering 117